Their focus on GLP-1 weight-loss protocols and growth-hormone peptide stacks (CJC-1295, Ipamorelin, Sermorelin) aligns well with the most in-demand peptide categories in 2026
Stangenberg, S
Capitalizing on over fifteen years of GLP-1 therapeutic applications, implementing these medications in addressing diabetes and obesity is progressively expanding
Maroon is frequently interviewed and quoted by the media, including the New York Times, USA Today, Associated Press, ESPN, Sports Illustrated, and ABC News Nightline
In another study, GPLC or a placebo was provided to resistance trained men for four weeks each, with a two-week washout period between each four-week period, using a double blind design
The study concluded that GHRP-6 is a potent synthetic GH secretagogue that stimulates GH release from the pituitary gland and will be studied further in clinical settings about GH deficiency, abdominal obesity, and cachexia in subjects in the future